Filing Flows › Core Scientific, Inc./tx (CORZ) › Capital expenditures
Core Scientific, Inc./tx (CORZ) capital expenditures by quarter
Core Scientific, Inc./tx's capital expenditures were $541M in Q3 2026 (third quarter 2026), +39% from Q1 2026. Over the last 5 quarters it ranged from $121M (Q2 2025) to $541M (Q3 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $541M | +39% | +121% |
| Q1 2026 | $389M | +39% | — |
| Q4 2025 | $279M | +14% | — |
| Q3 2025 | $244M | +102% | — |
| Q2 2025 | $121M | — | — |
Q3 2026 at a glance
Core Scientific, Inc./tx, Q3 2026: revenue $233M (+187% year over year), operating margin 31.1%, net earnings $1.2B, operating cash flow $65.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Core Scientific, Inc./tx's capital expenditures?
Core Scientific, Inc./tx's capital expenditures were $541M in Q3 2026 (third quarter 2026), +39% from Q1 2026.
How has Core Scientific, Inc./tx's capital expenditures changed?
Over the last 5 quarters it ranged from $121M (Q2 2025) to $541M (Q3 2026).
Q3 2026 results → · How Core Scientific, Inc./tx makes money →